Abstract
Quantitative structure activity relationship approach using enhanced replacement method for variable selection was applied to a series of imidazole containing tetrahydrobenzodiazepines as inhibitors of farnesyltransferase. For the purpose the dataset was divided into training set of 31 compounds and test set of 5 compounds using k means clustering. Statistically significant equations were obtained with high correlation coefficient coefficient (R=0.9637) and low standard deviation (S=0.3715). The robustness of the model was confirmed with the help of R2cv with a value of 0.8886, Y scrambling and by predicting the activities of test compounds. A good correlation of KierA3 shape indices and polarizability with the farnesyltransferase inhibitory activity was achieved.
Keywords: QSAR, Farnesyltransferase Inhibitors, Tetrahydrobenzodiazepines, Y scrambling, Polarizability, Imidazole, Ras proteins, PFT inhibitors, metalloenzyme, GABAA, Kubinyi function (FIT), apol, Specific Polarizability, Spol(R4)
Letters in Drug Design & Discovery
Title: Exploring the Structure Activity Relationships of Imidazole Containing Tetrahydrobenzodiazepines as Farnesyltransferase Inhibitors: A QSAR Study
Volume: 8 Issue: 6
Author(s): Anand Gaurav, Vertika Gautam and Ranjit Singh
Affiliation:
Keywords: QSAR, Farnesyltransferase Inhibitors, Tetrahydrobenzodiazepines, Y scrambling, Polarizability, Imidazole, Ras proteins, PFT inhibitors, metalloenzyme, GABAA, Kubinyi function (FIT), apol, Specific Polarizability, Spol(R4)
Abstract: Quantitative structure activity relationship approach using enhanced replacement method for variable selection was applied to a series of imidazole containing tetrahydrobenzodiazepines as inhibitors of farnesyltransferase. For the purpose the dataset was divided into training set of 31 compounds and test set of 5 compounds using k means clustering. Statistically significant equations were obtained with high correlation coefficient coefficient (R=0.9637) and low standard deviation (S=0.3715). The robustness of the model was confirmed with the help of R2cv with a value of 0.8886, Y scrambling and by predicting the activities of test compounds. A good correlation of KierA3 shape indices and polarizability with the farnesyltransferase inhibitory activity was achieved.
Export Options
About this article
Cite this article as:
Gaurav Anand, Gautam Vertika and Singh Ranjit, Exploring the Structure Activity Relationships of Imidazole Containing Tetrahydrobenzodiazepines as Farnesyltransferase Inhibitors: A QSAR Study, Letters in Drug Design & Discovery 2011; 8(6) . https://dx.doi.org/10.2174/157018011795906758
DOI https://dx.doi.org/10.2174/157018011795906758 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
MicroRNAs in Cancer Gene Therapy: Another Look
Current Cancer Therapy Reviews Factors Affecting Photodynamic Therapy and Anti-Tumor Immune Response
Anti-Cancer Agents in Medicinal Chemistry Alpha-1-Adrenergic Receptor Blockade Modifies Insulin-Regulated Aminopeptidase (IRAP) Activity in Rat Prostate and Modulates Oxytocin Functions
Drug Metabolism Letters Copper Compounds in Anticancer Strategies
Current Medicinal Chemistry Experimental Onco-Immunology Revisited
Current Cancer Therapy Reviews Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma
Current Pharmaceutical Biotechnology Methodological Issues of Clinical Research with EGFR Inhibitors
Current Cancer Therapy Reviews Research Advances on Anticancer Effect of Licorice
Current Bioactive Compounds Non-transfusion Dependent Thalassemias: A Developing Country Perspective
Current Pediatric Reviews Augmentation Therapy with Alpha1-antitrypsin: Novel Perspectives
Cardiovascular & Hematological Disorders-Drug Targets Meet Our Editorial Board Member:
Current Cancer Drug Targets Editorial [ Apoptotic Pathways as Targets for Therapeutic Intervention Guest Editor: Domagoj Vucic ]
Current Cancer Drug Targets Recent Patents of Gene Sequences Relative to the Phosphatidylinositol 3-kinase / Akt Pathway and their Relevance to Drug Discovery
Recent Patents on DNA & Gene Sequences Aerosol Processing of Crumpled Graphene Oxide-based Nanocomposites for Drug Delivery
Current Pharmaceutical Design Assessment of Expression of Homeobox A5 in Endometrial Cancer on the mRNA and Protein Level
Current Pharmaceutical Biotechnology Synthesis, Biochemical Evaluation and Rationalisation of a Series of 3,5- Dibromo Derivatives of 4-Hydroxyphenyl Ketone-Based Compounds as Probes of the Active Site of Type 3 of 17β-Hydroxysteroid Dehydrogenase (17β-HSD3) and the Role of Hydrogen Bonding Interaction in the Inhibition of 17β-HSD3
Letters in Drug Design & Discovery Editorial
Reviews on Recent Clinical Trials Radiation-Induced Pulmonary Epithelial-Mesenchymal Transition: A Review on Targeting Molecular Pathways and Mediators
Current Drug Targets PET Imaging of Multidrug Resistance in Tumors Using 18F-Fluoropaclitaxel
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Modulation of Proteostasis and Proteolytic Pathways as an Anti-Cancer Strategy)
Recent Patents on Anti-Cancer Drug Discovery